Lonidamine dimer-based nanomedicine for overcoming multidrug resistance by manipulating energy metabolism and disrupting redox homeostasis
A lonidamine dimer-based nanomedicine for overcoming multidrug resistant by manipulating energy metabolism and disrupting redox homeostasis.
Authors
- Dianyong Tang (ORCID: https://orcid.org/0000-0001-9389-870X)
- Yimei Zhang (ORCID: https://orcid.org/0000-0003-3125-8584)
- Zhong‐Zhu Chen (ORCID: https://orcid.org/0000-0001-9555-6738)
- Zheng Huang (ORCID: https://orcid.org/0000-0003-0033-8565)
- Yuan Chen (ORCID: https://orcid.org/0000-0001-9059-3839)
- Wenwen Yang (ORCID: https://orcid.org/0000-0002-7016-5666)
Institutions
- Chongqing University of Arts and Sciences (CN)
Publication Details
- Journal
- New Journal of Chemistry
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1039/d5nj02765a
- Citations
- 1
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.67